For: | Gomaa AI, Al-Khatib A, Abdel-Razek W, Hashim MS, Waked I. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging. World J Gastroenterol 2015; 21(18): 5654-5662 [PMID: PMC4427691 DOI: 10.3748/wjg.v21.i18.5654] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i18/5654.htm |
Number | Citing Articles |
1 |
Jianhua Tong, Panmiao Liu, Muhuo Ji, Ying Wang, Qiong Xue, Jian-Jun Yang, Cheng-Mao Zhou. Machine Learning Can Predict Total Death After Radiofrequency Ablation in Liver Cancer Patients. Clinical Medicine Insights: Oncology 2021; 15 doi: 10.1177/11795549211000017
|
2 |
Xiaowei Chi, Liejun Jiang, Yulin Yuan, Xinyan Huang, Xuemei Yang, Steven Hochwald, Jie Liu, Huayi Huang. A comparison of clinical pathologic characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from Eastern and Southern China. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02279-w
|
3 |
In Young Jo, Seok-Hyun Son, Myungsoo Kim, Soo Yoon Sung, Yong Kyun Won, Hye Jin Kang, So Jung Lee, Yong-An Chung, Jin Kyoung Oh, Chul-Seung Kay. Prognostic value of pretreatment18F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma. Radiation Oncology Journal 2015; 33(3): 179 doi: 10.3857/roj.2015.33.3.179
|
4 |
Rafael FERNANDES-FERREIRA, Graciele Domitila TENANI, Marcela Augusta de Souza PINHEL, Ana Margarida Coelho ABRANTES, Maria Filomena Rabaça Roque BOTELHO, Rita de Cássia Martins Alves da SILVA, Dorotéia Rossi Silva SOUZA, Renato Ferreira da SILVA. GENES EXPRESSION AND SERUM BIOMARKERS FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA, CIRRHOSIS AND HEPATITIS C. Arquivos de Gastroenterologia 2022; 59(3): 394 doi: 10.1590/s0004-2803.202203000-71
|
5 |
Chanhao Lei, Zihan Gao, Xingzhi Lv, Yanxue Zhu, Ruifang Li, Sanqiang Li. Saikosaponin-b2 Inhibits Primary Liver Cancer by Regulating the STK4/IRAK1/NF-κB Pathway. Biomedicines 2023; 11(10): 2859 doi: 10.3390/biomedicines11102859
|
6 |
Q. Wang, P. Zhao, N. He, J. P. Sun, K. Li, C. R. Zang, Y. N. Zhao, Y. Zhao, Y. H. Zhang. Combination of the gamma-glutamyltransferase-to-prealbumin ratio and other indicators may be a novel marker for predicting the prognosis of patients with hepatocellular carcinoma undergoing locoregional ablative therapies. Infectious Agents and Cancer 2019; 14(1) doi: 10.1186/s13027-019-0266-1
|